BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15135982)

  • 1. The biological effects of five feline IFN-alpha subtypes.
    Baldwin SL; Powell TD; Sellins KS; Radecki SV; Cohen JJ; Milhausen MJ
    Vet Immunol Immunopathol; 2004 Jun; 99(3-4):153-67. PubMed ID: 15135982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunisation with a combination of two complementary feline calicivirus strains induces a broad cross-protection against heterologous challenges.
    Poulet H; Brunet S; Leroy V; Chappuis G
    Vet Microbiol; 2005 Mar; 106(1-2):17-31. PubMed ID: 15737470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning, expression, purification, and biological activity of five feline type I interferons.
    Wonderling R; Powell T; Baldwin S; Morales T; Snyder S; Keiser K; Hunter S; Best E; McDermott MJ; Milhausen M
    Vet Immunol Immunopathol; 2002 Oct; 89(1-2):13-27. PubMed ID: 12208047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time reverse transcription polymerase chain reaction assay to detect a broad range of feline calicivirus isolates.
    Wilhelm S; Truyen U
    J Virol Methods; 2006 Apr; 133(1):105-8. PubMed ID: 16266755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feline immunodeficiency virus lacks sensitivity to the antiviral activity of feline IFN-gamma.
    Tanabe T; Yamamoto JK
    J Interferon Cytokine Res; 2001 Dec; 21(12):1039-46. PubMed ID: 11798461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon mediated antiviral activity against salmonid fish viruses in BF-2 and other cell lines.
    Saint-Jean SR; Pérez-Prieto SI
    Vet Immunol Immunopathol; 2006 Mar; 110(1-2):1-10. PubMed ID: 16169598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assembly of feline calicivirus-like particle and its immunogenicity.
    Di Martino B; Marsilio F; Roy P
    Vet Microbiol; 2007 Feb; 120(1-2):173-8. PubMed ID: 17126499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the efficacy of the subcutaneous low recombinant feline interferon-omega administration protocol for feline chronic gingivitis-stomatitis in feline calicivirus-positive cats.
    Matsumoto H; Teshima T; Iizuka Y; Sakusabe A; Takahashi D; Amimoto A; Koyama H
    Res Vet Sci; 2018 Dec; 121():53-58. PubMed ID: 30359811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feline calicivirus strains isolated in Italy.
    Rinaldo D; Foti M; Bottari T; Fisichella V; Buonavoglia D
    Pol J Vet Sci; 2008; 11(4):359-61. PubMed ID: 19227135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and characterization of a novel feline IFN-omega.
    Yang LM; Xue QH; Sun L; Zhu YP; Liu WJ
    J Interferon Cytokine Res; 2007 Feb; 27(2):119-27. PubMed ID: 17316139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virulent systemic feline calicivirus infection: local cytokine modulation and contribution of viral mutants.
    Foley J; Hurley K; Pesavento PA; Poland A; Pedersen NC
    J Feline Med Surg; 2006 Feb; 8(1):55-61. PubMed ID: 16213763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of a calicivirus isolated from cats dying in an agitated state.
    Sato Y; Ohe K; Fukuyama M; Furuhata K; Kishikawa S; Sakai S; Kiuchi A; Hara M; Watanabe T; Ishikawa Y; Taneno A
    Vet Rec; 2004 Dec 18-25; 155(25):800-5. PubMed ID: 15651548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the IFN-β response to four feline caliciviruses: Infection in CRFK cells.
    Tian J; Zhang X; Wu H; Liu C; Liu J; Hu X; Qu L
    Infect Genet Evol; 2015 Aug; 34():352-60. PubMed ID: 26051884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue distribution of virus replication in cats experimentally infected with distinct feline calicivirus isolates.
    Truyen U; Geissler K; Hirschberger J
    Berl Munch Tierarztl Wochenschr; 1999 Sep; 112(9):355-8. PubMed ID: 10507186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibitory effects of interferon-alpha subtypes vary according to human liver cancer cell lines.
    Yano H; Yanai Y; Momosaki S; Ogasawara S; Akiba J; Kojiro S; Moriya F; Fukahori S; Kurimoto M; Kojiro M
    J Gastroenterol Hepatol; 2006 Nov; 21(11):1720-5. PubMed ID: 16984596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferation and colony-forming inhibition activities of recombinant feline interferon (rFeIFN) on various cells in vitro.
    Priosoeryanto BP; Tateyama S; Yamaguchi R; Uchida K
    Can J Vet Res; 1995 Jan; 59(1):67-9. PubMed ID: 7704845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of recombinant feline interferon on the replication of feline enteropathogenic viruses in vitro.
    Mochizuki M; Nakatani H; Yoshida M
    Vet Microbiol; 1994 Mar; 39(1-2):145-52. PubMed ID: 7515537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-year duration of immunity in cats following vaccination against feline rhinotracheitis virus, feline calicivirus, and feline panleukopenia virus.
    Gore TC; Lakshmanan N; Williams JR; Jirjis FF; Chester ST; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2006; 7(3):213-22. PubMed ID: 17039444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel nested PCR for the diagnosis of calicivirus infections in the cat.
    Marsilio F; Di Martino B; Decaro N; Buonavoglia C
    Vet Microbiol; 2005 Jan; 105(1):1-7. PubMed ID: 15607078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of salmonid fish viruses on Mx gene expression and resistance to single or dual viral infections.
    Saint-Jean SR; Pérez-Prieto SI
    Fish Shellfish Immunol; 2007 Aug; 23(2):390-400. PubMed ID: 17442587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.